OVERVIEW

The 8th Annual UCLA Diabetes Symposium is organized by David Geffen School of Medicine (DGSOM) at UCLA, Office of Continuing Medical Education and will be held on Nov 14, 2020.

Accreditation:
The Office of Continuing Medical Education, David Geffen School of Medicine at UCLA designates this live activity for a maximum of 3 AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

Description:
Diabetes poses a major healthcare challenge given its rising prevalence, cost, and risk of chronic complications and co-morbidities. Healthcare providers are required to address these concerns in a changing landscape of therapy and technology where treatments for diabetes continue to expand. The UCLA Annual Diabetes Symposium is a half-day CME program offering providers of varying backgrounds a chance to review optimal state-of-the-art patient care. Experts in the field will review current best practices, including updates in care, guidelines, and technology, as well as address co-morbidities including obesity and kidney disease management.

Objectives:
At the completion of this course, participants should be able to:
• Counsel patients on risks and benefits of type 2 diabetes medications
• Manage patients with type 2 diabetes mellitus
• Discuss diagnosis and treatment of diabetes kidney disease
• Describe the treatment of fatty liver disease in obesity and diabetes
• Discuss approaches to the treatment of obesity